Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

John M Sanders1, Subhash Ghosh, Julian M W Chan

  • 1Department of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, Illinois 61801, USA.

Journal of Medicinal Chemistry
|January 9, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Educational Inequalities in Well-Being in Later Life in Germany: The Role of Health Behaviours and Health Literacy.

medRxiv : the preprint server for health sciences·2026
Same author

Antifungal Activity of Lipophilic Bisphosphonates.

ACS infectious diseases·2026
Same author

Activity of Antibacterial/Antifungal Compounds against the Protozoan Parasite, <i>Toxoplasma gondii</i>.

ACS infectious diseases·2025
Same author

Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi.

ACS infectious diseases·2025
Same author

Anti-Parasitics with a Triple Threat: Targeting Parasite Enzymes, the Proton Motive Force, and Host Cell-Mediated Killing.

ACS infectious diseases·2025
Same author

Activity of Carbazole, Aminoguanidine and Diamine Anti-infectives against <i>Toxoplasma gondii</i>.

bioRxiv : the preprint server for biology·2025

Gammadelta T cells are activated by bisphosphonates, common in bone therapy. This study developed a 3D model predicting bisphosphonate activity, aiding immunotherapy drug design.

Area of Science:

  • Immunology
  • Medicinal Chemistry
  • Computational Chemistry

Background:

  • Gammadelta T cells are crucial for immune defense against infections and tumors.
  • Bisphosphonates, used for bone resorption, also activate gammadelta T cells.
  • Understanding this activation is key for developing novel immunotherapies.

Purpose of the Study:

  • To investigate gammadelta T cell activation by various bisphosphonates.
  • To develop a 3D pharmacophore model for bisphosphonate-induced gammadelta T cell activation.
  • To explore the relationship between bisphosphonate structure and gammadelta T cell activity.

Main Methods:

  • Comparative Molecular Similarity Index Analysis (CoMSIA) was used to build a quantitative structure-activity relationship (QSAR) model.

Related Experiment Videos

  • A training set of 45 compounds and an external test set of 16 compounds were utilized.
  • Pharmacophore models for gammadelta T cell activation and farnesyl pyrophosphate synthase (FPPS) inhibition were compared.

    • Main Results:

    • CoMSIA models achieved high predictive accuracy (R(2) ≈ 0.8-0.9, q(2) ≈ 0.5-0.6).
    • Predicted activities for external compounds were accurate within a factor of 4.5.
    • Bisphosphonate gammadelta T cell activation pharmacophores closely resemble those for FPPS inhibition, suggesting a shared mechanism.

    Conclusions:

    • Bisphosphonate activity in gammadelta T cell activation is strongly correlated with FPPS inhibition.
    • The developed 3D QSAR model accurately predicts bisphosphonate efficacy.
    • This research facilitates the design of new bisphosphonates for immunotherapy.